Achieve Life Sciences Inc.

NASDAQ:ACHV   3:59:52 PM EDT
4.96
-0.11 (-2.17%)
Products, Regulatory

Achieve Life Sciences Awarded Grant To Conduct Phase 2 Trial Of Cytisinicline In Nicotine E-Cigarette Users

Published: 06/01/2022 12:31 GMT
Achieve Life Sciences Inc. (ACHV) - Achieve Life Sciences Awarded Grant From the National Institutes of Health to Conduct Phase 2 Trial of Cytisinicline in Nicotine E-cigarette Users.
Achieve Life Sciences- Awarded $2.5 Million in Grant Funding From Nida of Nih.
Achieve Life Sciences Inc- Grant Award Will Provide Funding That Enables Achieve to Initiate Phase 2 Orca-v1 Clinical Trial.